Profile data is unavailable for this security.
About the company
Shield Therapeutics plc is a United Kingdom-based commercial stage specialty pharmaceutical company. The Company specializes in the development and commercialization of late-stage pharmaceuticals which address areas of unmet medical need. The Company's lead product, Feraccru/Accrufer (ferric maltol), is a stable, non-salt-based oral therapy for adults with iron deficiency with or without anemia. Ferric maltol is approved in the United States, European Union, United Kingdom and Switzerland for the treatment of iron deficiency with or without anemia in adults. Its pipeline product candidate, PT20, is an iron-based phosphate binder that has the potential to treat patients with hyperphosphatemia related to dialysis or non-dialysis dependent chronic kidney disease (CKD). PT20 has completed its Phase II pivotal study. Its subsidiaries include Shield Therapeutics (DE) GmbH, Shield TX (UK) Limited, Phosphate Therapeutics Limited, and others.
- Revenue in GBP (TTM)1.95m
- Net income in GBP-13.04m
- Incorporated2015
- Employees16.00
- LocationShield Therapeutics PLC3rd FlBaltic Business Quarters, Abbott's HillGATESHEAD NE8 3DUnited KingdomGBR
- Phone+44 191 511 8500
- Websitehttps://www.shieldtherapeutics.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Spectral MD Holdings Ltd | 12.65m | -944.16k | 49.78m | -- | -- | 4.17 | -- | 3.94 | -0.0072 | -0.0072 | 0.0949 | 0.0878 | -- | -- | -- | -- | -- | -- | -- | -- | 43.26 | -- | -7.46 | -- | -- | -71.92 | 0.00 | -- | 195.82 | -- | 139.74 | -- | -- | -- |
| Kanabo Group PLC | 15.00k | -2.41m | 53.65m | -- | -- | 8.04 | -- | 3,576.34 | -0.0096 | -0.0096 | 0.0001 | 0.018 | 0.0039 | -- | 0.0932 | -- | -62.27 | -- | -66.38 | -- | -26.67 | -- | -16,046.67 | -- | 24.36 | -- | 0.00 | -- | -- | -- | 63.91 | -- | -- | -- |
| Skinbiotherapeutics PLC | 0.00 | -1.43m | 56.05m | 7.00 | -- | 10.33 | -- | -- | -0.0097 | -0.0097 | 0.00 | 0.0346 | 0.00 | -- | -- | 0.00 | -32.98 | -31.20 | -35.80 | -32.97 | -- | -- | -- | -- | -- | -1,609.80 | 0.0251 | -- | -- | -- | 4.47 | -- | -3.79 | -- |
| Venture Life Group PLC | 27.05m | 347.00k | 57.25m | 119.00 | 108.59 | 0.8113 | 21.38 | 2.12 | 0.0042 | 0.0042 | 0.2364 | 0.5609 | 0.3467 | 1.92 | 2.69 | 227,268.90 | 0.4448 | 0.8494 | 0.5371 | 1.01 | 40.21 | 40.35 | 1.28 | 1.78 | 1.23 | -- | 0.1643 | -- | 48.85 | 27.07 | 161.95 | -- | 28.44 | -- |
| Destiny Pharma PLC | 0.00 | -5.47m | 63.76m | 14.00 | -- | 6.27 | -- | -- | -0.1058 | -0.1058 | 0.00 | 0.1698 | 0.00 | -- | -- | 0.00 | -65.43 | -40.73 | -70.34 | -43.29 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -14.93 | -- | 284.88 | -- |
| OKYO Pharma Ltd | 0.00 | -3.00m | 64.55m | 6.00 | -- | 11.61 | -- | -- | -0.0044 | -0.0044 | 0.00 | 0.0057 | 0.00 | -- | -- | 0.00 | -106.65 | -- | -157.37 | -- | -- | -- | -- | -- | -- | -3,496.67 | 0.0182 | -- | -- | -- | -146.83 | -- | -- | -- |
| Verici Dx Plc | -100.00bn | -100.00bn | 71.02m | 8.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 4d Pharma PLC | 490.00k | -67.69m | 74.28m | 115.00 | -- | 1.87 | -- | 151.60 | -0.4438 | -0.4438 | 0.0034 | 0.22 | 0.0112 | -- | 0.195 | 4,260.87 | -154.55 | -32.46 | -182.79 | -35.41 | -- | -- | -13,813.67 | -13,963.36 | 4.18 | -54.63 | 0.0248 | -- | 153.08 | -- | -7.88 | -- | -27.01 | -- |
| Yourgene Health PLC | 27.56m | -9.86m | 85.04m | 180.00 | -- | 2.47 | -- | 3.09 | -0.0137 | -0.0137 | 0.0382 | 0.0475 | 0.4972 | 3.26 | 3.81 | 153,094.60 | -17.79 | -24.79 | -21.58 | -33.69 | 60.29 | 57.85 | -35.79 | -53.90 | 1.34 | -11.62 | 0.1345 | -- | 10.08 | 49.46 | -400.58 | -- | 27.36 | -- |
| Shield Therapeutics PLC | 1.95m | -13.04m | 88.49m | 16.00 | -- | 1.73 | -- | 45.40 | -0.0817 | -0.0817 | 0.0122 | 0.2363 | 0.043 | 0.5348 | 1.54 | 121,812.50 | -28.76 | -24.56 | -30.15 | -27.03 | 61.31 | 89.95 | -668.91 | -199.87 | 17.86 | -451.48 | 0.00 | -- | 1,344.65 | -- | 70.11 | -- | -29.49 | -- |
| Science in Sport PLC | 56.04m | -837.00k | 93.90m | 197.00 | -- | 1.95 | 38.64 | 1.68 | -0.0061 | -0.0061 | 0.4205 | 0.356 | 0.8658 | 3.43 | 5.11 | 284,446.70 | -1.29 | -9.92 | -1.63 | -11.74 | 50.98 | 50.27 | -1.49 | -12.97 | 1.24 | -6.48 | 0.0147 | -- | -0.439 | 39.75 | 69.24 | -- | 32.13 | -- |
| Futura Medical plc. | 0.00 | -2.93m | 95.19m | 13.00 | -- | 7.33 | -- | -- | -0.0117 | -0.0117 | 0.00 | 0.0452 | 0.00 | -- | -- | 0.00 | -34.96 | -58.52 | -38.86 | -74.23 | -- | -- | -- | -4,391.39 | 18.60 | -- | 0.00 | -- | -100.00 | -- | 73.00 | -- | -12.11 | -- |
| C4X Discovery Holdings PLC | 5.64m | -3.84m | 97.86m | 46.00 | -- | 5.05 | -- | 17.34 | -0.0228 | -0.0228 | 0.0288 | 0.0847 | 0.3635 | -- | 11.15 | 122,652.20 | -24.77 | -60.05 | -27.63 | -68.53 | 98.40 | 99.28 | -68.13 | -237.08 | -- | -420.93 | 0.0205 | -- | -- | 82.46 | 50.65 | -- | -13.79 | -- |
| Diurnal Group PLC | 4.37m | -10.05m | 107.41m | 36.00 | -- | 2.84 | -- | 24.57 | -0.0733 | -0.0733 | 0.0319 | 0.2237 | 0.1393 | 0.5436 | 11.59 | 121,416.70 | -32.02 | -43.08 | -35.86 | -50.33 | 82.18 | -- | -229.90 | -427.57 | 9.59 | -- | 0.00 | -- | -30.76 | -- | -146.78 | -- | -- | -- |
| Eco Animal Health Group Plc | 101.55m | 5.57m | 125.29m | 207.00 | 22.47 | 1.50 | 8.84 | 1.23 | 0.0823 | 0.0823 | 1.50 | 1.23 | 0.9131 | 2.17 | 3.60 | 490,584.50 | 11.31 | 10.55 | 15.40 | 13.14 | 49.93 | 48.53 | 12.38 | 14.62 | 2.57 | -- | 0.0145 | 47.19 | 46.46 | 17.51 | 109.45 | 6.21 | -30.72 | -29.40 |
Data as of Jan 18 2022. Currency figures normalised to Shield Therapeutics PLC's reporting currency: UK Pound GBX
24.14%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Hargreaves Lansdown Stockbrokers Ltd.as of 02 Nov 2021 | 11.51m | 5.33% |
| JPMorgan Asset Management (UK) Ltd.as of 10 Apr 2018 | 6.24m | 2.89% |
| Hargreaves Lansdown Asset Management Ltd.as of 02 Nov 2021 | 6.09m | 2.82% |
| Rahn+Bodmer Co.as of 02 Nov 2021 | 5.65m | 2.62% |
| USS Investment Management Ltd.as of 19 Mar 2021 | 5.07m | 2.35% |
| BlackRock Investment Management (UK) Ltd.as of 02 Nov 2021 | 5.01m | 2.32% |
| Jarvis Investment Management Ltd.as of 02 Nov 2021 | 4.95m | 2.29% |
| HSBC Bank Plc (Market-Maker)as of 02 Nov 2021 | 2.68m | 1.24% |
| IG Markets Ltd.as of 02 Nov 2021 | 2.62m | 1.21% |
| Investec Wealth & Investment Ltd.as of 02 Nov 2021 | 2.29m | 1.06% |
More ▼
Data from 30 Sep 2021 - 03 Jan 2022Source: FactSet Research Systems Inc.
